Health Systems Working Together Strengthen Their In-House Specialty Pharmacy Capabilities and Optimize Patient Carehttps://shieldshealthsolutions.com/content/uploads/2021/06/shields-blog-icon-case-whitepaper.svg204115Shields Health SolutionsShields Health Solutions//shieldshealthsolutions.com/content/uploads/2021/05/shields-logo-white.svg
This white paper provides background on the specialty pharmacy market, describes the role of health systems in specialty pharmacy care, acknowledges the challenges they face, and outlines the benefits of…
Excelera® Welcomes Diane Wolfe as National Director of Manufacturer Relationshttps://shieldshealthsolutions.com/content/uploads/2021/06/shields-blog-icon-pr-1.svg204115Shields Health SolutionsShields Health Solutions//shieldshealthsolutions.com/content/uploads/2021/05/shields-logo-white.svg
Wolfe joins Excelera with significant experience in building strategic pharmaceutical manufacturer relationships for publicly traded and private organizations in the healthcare sector
Excelera Announces Key Hires to Support Expanded Product and Service Offeringshttps://shieldshealthsolutions.com/content/uploads/2021/06/shields-blog-icon-pr-1.svg204115Shields Health SolutionsShields Health Solutions//shieldshealthsolutions.com/content/uploads/2021/05/shields-logo-white.svg
Updates include additions to the leadership team, enhanced technology platform capabilities to track electronic health record data and expanded product portfolio
New Combination Therapies for the Treatment of Chronic Lymphocytic Leukemiahttps://shieldshealthsolutions.com/content/themes/blade/images/empty/thumbnail.jpg150150Shields Health SolutionsShields Health Solutions//shieldshealthsolutions.com/content/uploads/2021/05/shields-logo-white.svg
Erin Kelley, PharmD, BCOP, and Jeff Engle, PharmD, MS, Fairview Health
CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) is the most common type of leukemia in adults and accounts for approximately 37% of new leukemia cases. An estimated 20,720 new cases of and 3930 deaths from CLL will occur in the United States in 2019.
Growth of Health System-Based Specialty Pharmacy to Continue in 2020, Reducing Cost of Carehttps://shieldshealthsolutions.com/content/themes/blade/images/empty/thumbnail.jpg150150Shields Health SolutionsShields Health Solutions//shieldshealthsolutions.com/content/uploads/2021/05/shields-logo-white.svg
By Don Amorosi, Chief Operating Officer; and Becky Rand, MHRM, Vice President of Manufacturer Relations ExceleraRx Corp
Although the prevalence of health system-based specialty pharmacies has grown steadily over the past decade, 2020 will mark a critical year. Payers, providers, and health systems themselves are increasingly recognizing the important role integrated delivery solutions play in value-based care initiatives.
Excelera® Welcomes Experienced Healthcare Executive as National Vice President of Saleshttps://shieldshealthsolutions.com/content/uploads/2021/06/shields-blog-icon-pr-1.svg204115Shields Health SolutionsShields Health Solutions//shieldshealthsolutions.com/content/uploads/2021/05/shields-logo-white.svg
Meredith Holt joins Excelera with over 20 years of experience establishing and expanding health care initiatives, programs and relationships.
Excelera Expands Solutions for Members, Manufacturers and Payers, Improving Complex Patient Care in 2019https://shieldshealthsolutions.com/content/uploads/2021/06/shields-blog-icon-pr-1.svg204115Shields Health SolutionsShields Health Solutions//shieldshealthsolutions.com/content/uploads/2021/05/shields-logo-white.svg